by The global genotyping market size was approximate at US$ 16.9 billion in 2022 and is anticipated to grow US$ 67.60 billion by 2032, registering a compound annual growth rate of 14.87% from 2023 to 2032.
The genotyping market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the genotyping market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the genotyping report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the genotyping market have been studied and analysed across many developments.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2983
Genotyping Market Report Scope
| Report Coverage | Detail |
| Market Size in 2023 | USD 19.41 Billion |
| Market Size by 2032 | USD 67.60 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 14.87% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 To 2032 |
| Segments Covered | By Product, By Application, By Technology, and By End Users |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Also read: Cell-based Assays Market Size to Grow US$ 42.32 Billion By 2032
Research Approach
The comprehensive report on the global genotyping market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global genotyping market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- Illumina Inc
- Thermo Fisher Scientific Inc.
- Qiagen Inc.
- F. Hoffmann-La Roche Ltd.
- Fluidigm Corporation
- Danaher Corporation
- Agilent Technologies
- Eurofins Scientific Inc.
- GE Healthcare Inc.
- Bio-Rad Laboratories Inc.
- Pacific Biosciences of California
Genotyping Market Segmentations
By Product
- Instruments
- Sequencers & Amplifiers
- Analyzers
- Reagents & Kits
- Software and Services
- Genotyping Services
By Application
- Pharmacogenomics
- Diagnostics and Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Others
By Technology
- PCR
- Real-time PCR
- Digital PCR
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restriction Fragment Length Polymorphism
- Single-Strand Conformation Polymorphism
- Microarrays
- DNA Microarrays
- Peptide Microarrays
- Others
- Sequencing
- Next Generation Sequencing
- Pyro Sequencing
- Sanger Sequencing
- Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
- Others
By End Users
- Pharmaceutical And Biopharmaceutical Companies
- Diagnostics And Research Laboratories
- Academic Institutes
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Genotyping Market
5.1. COVID-19 Landscape: Genotyping Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Genotyping Market, By Product
8.1. Genotyping Market, by Product, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Sequencers & Amplifiers
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Analyzers
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Reagents & Kits
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Software and Services
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Genotyping Services
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Genotyping Market, By Application
9.1. Genotyping Market, by Application, 2023-2032
9.1.1. Pharmacogenomics
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Diagnostics and Personalized Medicine
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Agricultural Biotechnology
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Animal Genetics
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Genotyping Market, By March
10.1. Genotyping Market, by March, 2023-2032
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Capillary Electrophoresis
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Microarrays
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Sequencing
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Genotyping Market, By End Users
11.1. Genotyping Market, by End Users, 2023-2032
11.1.1. Pharmaceutical And Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Diagnostics And Research Laboratories
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Academic Institutes
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Genotyping Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.3. Market Revenue and Forecast, by March (2020-2032)
12.1.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.3. Market Revenue and Forecast, by March (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.3. Market Revenue and Forecast, by March (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.3. Market Revenue and Forecast, by March (2020-2032)
12.2.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.3. Market Revenue and Forecast, by March (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.3. Market Revenue and Forecast, by March (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.3. Market Revenue and Forecast, by March (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.3. Market Revenue and Forecast, by March (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.3. Market Revenue and Forecast, by March (2020-2032)
12.3.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.3. Market Revenue and Forecast, by March (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.3. Market Revenue and Forecast, by March (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.3. Market Revenue and Forecast, by March (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.3. Market Revenue and Forecast, by March (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.3. Market Revenue and Forecast, by March (2020-2032)
12.4.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.3. Market Revenue and Forecast, by March (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.3. Market Revenue and Forecast, by March (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.3. Market Revenue and Forecast, by March (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End Users (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.3. Market Revenue and Forecast, by March (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.3. Market Revenue and Forecast, by March (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End Users (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.3. Market Revenue and Forecast, by March (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End Users (2020-2032)
Chapter 13. Company Profiles
13.1. Illumina Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Qiagen Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Fluidigm Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Danaher Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Agilent Technologies
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Eurofins Scientific Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Bio-Rad Laboratories Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global genotyping market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for genotyping are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
